Abstract:Although many researchers of Parkinson's disease (PD) have shifted their focus from the central nervous system (CNS) to the peripheral blood, a significant knowledge gap remains between PD severity and the peripheral immune response. In the current study, we aimed to map the peripheral immunity atlas in peripheral blood mononuclear cells (PBMCs) from PD patients and healthy controls using single-cell RNA sequencing (scRNA-seq). Our study employed scRNA-seq analysis to map the peripheral immunity atlas in PD by profiling PBMCs from PD-Early, PD-Late patients and matched controls. By enlarging the blood sample size, we validated the roles of NK cells in numerous immune-related biological processes. We also detected the infiltration of NK cells into the cerebral motor cortex as the disease progressed, using human brain sections, and elucidated the communication between the periphery and CNS and its implications for PD. As a result, cell subpopulation atlases in PBMCs from PD patients and healthy controls along with differentially expressed genes in NK cells were identified by scRNA-seq analysis, representing 6 major immune cell subsets among which NK cells declined in the progression of PD. We further validated NK cell reduction in increasing samples and found that they participated in numerous immune-related biological processes and infiltration into the cerebral motor cortex as the disease proceeded, evidencingd the close communication between the peripheral immune response and CNS. Strikingly, XCL2 positively correlated with PD severity, with good predictive performance of PD and specific expression in subclusters C2 and C5 of NK cells. All these findings delineated the critical role of peripheral immune response mediated by NK cells in the pathogenesis of PD. NK cell-specific XCL2 could be used as a diagnostic marker for treating PD. The indispensable function of NK cells and NK cell-specific molecular biomarkers highlighted the implication of the peripheral immune response in PD progression. Trial registration: ChiCTR, ChiCTR1900023975. Registered 20 June 2019 - Retrospectively registered, https://www.chictr.org.cn/showproj.html?proj=31035 .

Single-Cell RNA Sequencing in Parkinson’s Disease

Single-Cell Sequencing Insights into the Transcriptional Landscape of Parkinson's Disease

Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases

Single-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease

Single-cell transcriptomic atlas of the human substantia nigra in Parkinson’s disease

Single-cell brain atlas of Parkinson's disease mouse model

Single-cell transcriptomic and proteomic analysis of Parkinson’s disease Brains

Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases

Comprehensive review on single-cell RNA sequencing: A new frontier in Alzheimer's disease research

Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing

Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains

Defining Specific Cell States of MPTP-Induced Parkinson's Disease by Single-Nucleus RNA Sequencing

Single-Cell Sequencing in Neurodegenerative Disorders

Integrated Analysis of Single-Cell RNA Sequencing and Bulk Transcriptome Data Identifies a Pyroptosis-Associated Diagnostic Model for Parkinson’s Disease

Single-Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Parkinson’s Disease

Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease

The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery

Cell–Cell Communication Alterations Via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease

Advancements in Single-Cell RNA Sequencing and Spatial Transcriptomics for Central Nervous System Disease

Interpretable machine learning classifiers implicate GPC6 in Parkinson's disease from single-nuclei midbrain transcriptomes

Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution